terraplasma medical GmbH

terraplasma medical GmbH is a German medical-technology company based in Garching, near Munich, that develops and markets medical devices based on cold atmospheric plasma (CAP). It was founded in 2016 as a subsidiary of terraplasma GmbH, itself a spin-off of the Max Planck Society, with the explicit goal of translating decades of cold-plasma research into practical clinical applications. The scientific roots of the technology reach back more than three decades to work at the Max Planck Institute for Extraterrestrial Physics under Prof. Dr. Dr. h.c. Gregor Morfill, whose research spanned astrophysics, complex plasmas and — notably — plasma-crystallization experiments under microgravity aboard the International Space Station. Those experiments deepened the understanding of plasma physics and laid groundwork for medical cold-plasma technologies. The company's flagship product is plasma care®, a handheld, portable medical device that generates cold atmospheric plasma from ambient air. It is CE-certified as a medical device and is positioned for the treatment of acute and chronic wounds, as well as for dermatology and podiatry applications. The device is marketed to specialist users, partners and patients, and the company presents its technology as safe, effective and scientifically grounded. Its stated mission is to revolutionize wound healing with breakthrough cold-plasma technology, framed by the narrative "from spaceflight to medicine." terraplasma medical operates as a private subsidiary within the terraplasma group. Its parent, terraplasma GmbH, is a Max Planck Society spin-off, giving the medical subsidiary a direct lineage to publicly funded fundamental research. The company is headquartered in Garching, Germany, and its commercial focus is on the German and broader European healthcare markets, where CE marking is required for medical devices. The brand identity combines a deep-science heritage with a practical clinical product: plasma care® is designed to be mobile and easy to use, distinguishing it from larger stationary plasma systems. Because the company is a relatively young medical-technology firm, its public profile centers on the plasma care® product family, clinical evidence for cold-plasma wound treatment, and its Max Planck research pedigree. The official website organizes its offering around wound care, dermatology and podiatry, and provides background material on cold-plasma technology for professional users. As a subsidiary rather than a listed company, terraplasma medical does not report publicly traded shares; its ownership sits with terraplasma GmbH.

terraplasma medical GmbH was founded in 2016 as a subsidiary of terraplasma GmbH, a spin-off of the Max Planck Society. Its creation was driven by the goal of transferring breakthrough findings in cold-plasma research into practical medical applications. The scientific origins of the technology extend back more than three decades and were substantially developed at the Max Planck Institute for Extraterrestrial Physics under the leadership of Prof. Dr. Dr. h.c. Gregor Morfill. His work covered not only astrophysical questions but also the investigation of complex plasmas and their potential medical uses. A notable aspect of Prof. Morfill's research was the execution of plasma-crystallization experiments under microgravity conditions aboard the International Space Station (ISS). These experiments enabled a deeper understanding of plasma physics and laid the foundation for the development of cold-plasma technologies now used in medicine. With the founding of terraplasma medical GmbH, the vision of making cold plasma usable for the treatment of chronic and acute wounds was realized. The company developed plasma care®, a mobile, CE-certified medical device that generates cold plasma to target bacteria and support wound treatment. The product is presented as a handheld, portable medical device that generates cold atmospheric plasma from ambient air, and it is marketed for wound care, dermatology and podiatry. The company frames its work with the narrative "from spaceflight to medicine" and emphasizes that its plasma care® technology sets new standards in the treatment of acute and chronic wounds, described as safe, effective and scientifically grounded. As a subsidiary within the terraplasma group, terraplasma medical is headquartered in Garching, Germany. It operates as a private company and does not have publicly traded shares. Its commercial focus is on the German and European healthcare markets, where its CE-certified device can be sold for medical use. The company addresses specialist users, partners and patients through its official website, which organizes information around wound care, dermatology, podiatry and background knowledge on cold-plasma technology.

• 2016

  terraplasma medical GmbH founded as a subsidiary of terraplasma GmbH, a Max Planck Society spin-off.

• Development of plasma care®, a mobile, CE-certified medical device generating cold atmospheric plasma from ambient air.

• Research origins: over three decades of cold-plasma research at the Max Planck Institute for Extraterrestrial Physics under Prof. Dr. Dr. h.c. Gregor Morfill, including plasma-crystallization experiments aboard the ISS.

Developer and marketer of CE-certified, portable cold atmospheric plasma medical devices for wound care, dermatology and podiatry, with a Max Planck research heritage.

• plasma care®

  Handheld, portable CE-certified medical device that generates cold atmospheric plasma from ambient air, indicated for wound care, dermatology and podiatry.

1. 1plasma care - Die mobile Behandlungs-Lösung mit kaltem Plasmaterraplasma-medical.com
2. 2Über uns - terraplasma medicalterraplasma-medical.com
3. 3terraplasma medical GmbH (Germany) - Wikidatawikidata.org